$PAHC (Phibro Animal Health Corporation)

$PAHC {{ '2016-08-29T20:54:39+0000' | timeago}} • Announcement

$PAHC expects net sales of $750-770MM for FY17, up to 2% growth over 2016. Animal Health sales are expected to be $495-510MM, an increase of 2-5%. Mineral Nutrition revenue is to decline slightly, with volume growth offset by reduced pricing related to commodity prices. Performance Products revenue is expected to be stable or decline slightly.

$PAHC {{ '2017-11-07T14:26:50+0000' | timeago}} • Announcement

$PAHC's BoD declared a quarterly cash dividend of $0.10 per share on its Class A and B common stock. The dividend is payable on Dec. 27, 2017 to stockholders of record as of Dec. 6, 2017.

$PAHC {{ '2017-09-12T19:42:34+0000' | timeago}} • Announcement

$PAHC said it has decided to acquire Biotay SA, a manufacturer of animal health and nutritional products. The acquisition will strengthen the company’s core business and mark its entry into the South American market. Phibro Animal Health did not disclose the financial terms of the transaction.

$PAHC {{ '2017-07-24T21:23:09+0000' | timeago}} • Announcement

$PAHC BoD declared a quarterly cash dividend of $0.10 per share on its Class A and Class B common stock. The dividend is payable on Sept. 27, 2017, to stockholders of record at the close of business on Sept. 6, 2017.

$PAHC {{ '2017-05-09T11:48:56+0000' | timeago}} • Announcement

$PAHC BoD declared a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock. The dividend is payable on June 22, 2017, to stockholders of record at the close of business on May 31, 2017.

$PAHC {{ '2017-02-07T14:01:47+0000' | timeago}} • Announcement

$PAHC's BoD declared a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock. The dividend is payable on March 22, 2017, to stockholders of record at the close of business on March 1, 2017.

$PAHC {{ '2016-08-30T14:18:06+0000' | timeago}} • Webcast

Credit Suisse analyst Erin Wilson asks in which international geographies there is strength seen and what's driving it. $PAHC says that it is seeing strength in South America, Latin America, far East, China & Eastern Europe. For FY16-end, kilos sold of overall MFAs were higher. The shift in US is more driven by the consumer and market needs.

$PAHC {{ '2016-08-30T14:05:52+0000' | timeago}} • Webcast

Morgan Stanley analyst David Risinger asks how much of a negative impact does customers moving away from MFAs have on the 2017 guidance. $PAHC says that the market is still working on how to work on antibiotics. The market is definitely staying and customers are moving because the company has not gone through the full cycle of quality of feed.

$PAHC {{ '2016-08-30T13:58:45+0000' | timeago}} • Webcast

Guggenheim Securities analyst Brandon Folkes questions about 2017 pricing potential & assumptions in guidance. $PAHC says that 2017 guidance has very modest or minimal pricing assumptions. When talking about sales, $PAHC is really talking about volume growth. Some actions may be taken for individual products, but it's not the driver of business.

$PAHC {{ '2016-08-30T13:44:22+0000' | timeago}} • Webcast

$PAHC said that its leverage ratio was 3.1 times at June 30, with $353MM of total debt against $114MM of adjusted EBITDA. The company had $34MM of cash on the balance sheet at June 30. 4Q16 cash flow was $19MM source of cash and routine quarterly dividends were $3.9MM that was paid in June and the same amount was declared to be paid in Sept.

$PAHC {{ '2016-08-30T13:33:32+0000' | timeago}} • Webcast

For 4Q16, $PAHC's Animal Health sales rose almost 7%, helped by volume growth across all product groups where MFAs rose 3%, nutritional specialty was up 14% and vaccines rose 29%. Mineral Nutrition sales fell 9% to about $50MM vs. 4Q15 due to commodity pricing. Performance Products sales rose $800,000, while adjusted EBITDA fell $100,000 vs. 4Q15.

$PAHC {{ '2016-08-30T13:24:57+0000' | timeago}} • Webcast

During 4Q16, $PAHC's consolidated sales rose 2% YoverY, which was about $4MM of sales growth. This was helped by volume growth in the Animal Health segment. Sales of Mineral Nutrition were below 4Q15 & Performance Products sales were up slightly YoverY. Consolidated reported gross profit fell 1% and adjusted gross profit rose 2%, driven by volumes.

$PAHC {{ '2016-08-30T13:16:56+0000' | timeago}} • Webcast

Maker of animal nutrition products $PAHC said that the current annual sales of medically important antibacterials was $37MM and on the international side, the company has seen continued volume growth of MFAs. $PAHC is also experiencing nice double-digit growth both in the nutritional specialty portfolio, as well as vaccines.

$PAHC {{ '2016-08-29T20:56:41+0000' | timeago}} • Announcement

$PAHC expects adjusted EBITDA of $116-120MM in FY17, growth of 2-5%. The company expects adjusted diluted EPS of $1.38-1.45, a decrease of 3% to an increase of 1% from last year. Adjusted effective rate for income taxes is expected to be approx. 29.5% for 2017, similar to the revised adjusted effective rate for 2016.

$PAHC {{ '2016-08-29T20:54:39+0000' | timeago}} • Announcement

$PAHC expects net sales of $750-770MM for FY17, up to 2% growth over 2016. Animal Health sales are expected to be $495-510MM, an increase of 2-5%. Mineral Nutrition revenue is to decline slightly, with volume growth offset by reduced pricing related to commodity prices. Performance Products revenue is expected to be stable or decline slightly.

$PAHC {{ '2016-08-29T20:52:02+0000' | timeago}} • Announcement

$PAHC said its Animal Health net sales of $126.2MM for 4Q16 grew $8.7MM or 7% from 4Q15. Mineral Nutrition net sales of $50.3MM decreased $5.3MM or 9% from last year. Performance Products net sales of $12.7MM increased $0.8MM or 6% from a year ago.

$PAHC {{ '2016-08-29T20:50:15+0000' | timeago}} • Announcement

$PAHC reported improved earnings in 4Q16, helped by foreign currency gains compared to 4Q15. Net income was $15.2MM or $0.38 per diluted share compared to $10.4MM or $0.26 per diluted share last year. Net sales grew 2% from 4Q15 to $189MM. Adjusted diluted EPS fell 9% to $0.40 in 4Q16.

$PAHC {{ '2016-05-09T20:36:11+0000' | timeago}} • Announcement

Animal health and nutrition company $PAHC said that its BoD declared a quarterly dividend of $0.10 per share on its Class A common stock and Class B common stock. This cash dividend is payable on June 22, 2016, to the company's stockholders of record on June 1, 2016.

$PAHC {{ '2016-04-08T20:37:13+0000' | timeago}} • Announcement

Animal health products company $PAHC said the U.S. FDA stated its intention to withdraw its approval for antibiotic drug Mecadox, used for controlling bacterial diseases like Salmonella and Swine dysentry, citing safety reasons. Today's action by the FDA does not prohibit the sale or use of Mecadox in the United States, the company added.

$PAHC {{ '2016-02-09T06:22:39+0000' | timeago}} • Announcement

Animal health and nutrition products maker $PAHC said its BoD has declared a quarterly dividend of $0.10 per share on its Class A and Class B common stock payable on March 23, 2016 to stockholders of record on March 2, 2016.

$PAHC {{ '2016-01-25T22:25:36+0000' | timeago}} • Announcement

$PAHC said it has completed its purchase of Omaha, Nebraska-based MVP Laboratories, Inc.'s assets, which was announced on January 12, 2016.

Recent Transcripts

CAG (ConAgra Foods, Inc.)
Thursday, December 21 2017 - 2:30pm
GIS (General Mills, Inc.)
Wednesday, December 20 2017 - 1:30pm
GES (Guess' Inc.)
Tuesday, November 21 2017 - 9:45pm
CPB (Campbell Soup Company)
Tuesday, November 21 2017 - 1:30pm
FLO (Flowers Foods, Inc.)
Thursday, November 9 2017 - 1:30pm
DAR (Darling Ingredients Inc.)
Wednesday, November 8 2017 - 1:30pm
KIN (Kindred Biosciences, Inc.)
Tuesday, November 7 2017 - 9:30pm
PAHC (Phibro Animal Health Corporation)
Tuesday, November 7 2017 - 2:00pm
HAIN (The Hain Celestial Group, Inc.)
Tuesday, November 7 2017 - 1:30pm
PETX (Aratana Therapeutics, Inc.)
Friday, November 3 2017 - 12:30pm
ZTS (Zoetis Inc.)
Thursday, November 2 2017 - 12:30pm
GIL (Gildan Activewear Inc.)
Thursday, November 2 2017 - 12:30pm
BG (Bunge Limited)
Wednesday, November 1 2017 - 12:00pm
BGS (B&G Foods Inc.)
Tuesday, October 31 2017 - 8:30pm
FDP (Fresh Del Monte Produce Inc.)
Tuesday, October 31 2017 - 3:00pm
ADM (Archer-Daniels-Midland Company)
Tuesday, October 31 2017 - 1:00pm
FMX (Fomento Económico Mexicano, S.A.B de C.V)
Friday, October 27 2017 - 1:00pm
GNC (GNC Holdings Inc.)
Thursday, October 26 2017 - 12:30pm
HSY (The Hershey Company)
Thursday, October 26 2017 - 12:30pm
HOG (Harley-Davidson, Inc.)
Tuesday, October 17 2017 - 1:00pm

AlphaGraphics you may like